Mercy BioAnalytics, Inc.
Nadish Goyal is a seasoned scientist with extensive experience in molecular diagnostics and biochemistry. Currently serving as a Senior Scientist at Mercy BioAnalytics, Inc., commencing April 2024, Nadish previously held similar positions at Sherlock Biosciences and played pivotal roles in research and development at HelixBind, Inc. and PhenGen BioTech. Academic credentials include a Doctor of Philosophy in Biochemistry from Drexel University College of Medicine, a Master’s Degree in Biotechnology from the University of Pennsylvania, and a Bachelor of Technology in Biotechnology from Thapar University. Notable contributions include leading efforts in developing a novel molecular diagnostic technology for Lyme disease and optimizing assay transitions for pathogen identification.
This person is not in any teams
Mercy BioAnalytics, Inc.
Mercy BioAnalytics is a biotechnology company that aims to improve and save the lives of people through the early detection of cancer.It has developed a process that uses nano-particles that are extraordinarily abundant in blood and carry information about their parent cell – known as extracellular vesicles, or EVs – to detect stage I cancer.Paul Blavin and Joseph Sedlak founded the Natick, Massachusetts-based company in 2018.